Government ❯Justice Department ❯Regulatory Actions

Healthcare Regulations

Antitrust Division False Claims Act Fraud Enforcement

Pfizer Settles $59.7M Kickback Allegations Tied to Acquired Migraine Drug

The settlement resolves claims that Biohaven, acquired by Pfizer in 2022, used improper financial incentives to boost prescriptions of Nurtec ODT.

Justice Department Files Suit to Block UnitedHealth's $3.3 Billion Amedisys Acquisition